Ranbaxy brand may fade away as Sun takes charge

The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......

New drug policy welcome move: Pharma companies

The new drug price control policy that has recently been notified is likely to be a boon for consumers as it will put an end to the 'arbitrary' pricing regime and bring down medicine prices, say......

Pharmaceutical firms opt for inlicensing

Ranbaxy Laboratories, Dr Reddy's Laboratories, Nicholas Piramal and other pharmaceutical companies are betting on inlicensing or strategic marketing tie-ups to help grow local sales after India......

Indian pharmaceutical M&As see unhealthy decline

The value of mergers and acquisitionsby Indian pharmaceutical and healthcare companies has declined sharply in the second half (H2) of 2007-08, suggesting that heady days of large buyouts are......